Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

Market Cap	1.12T
Revenue (ttm)	397.55B
Net Income (ttm)	127.36B
Shares Out	21.50M
EPS (ttm)	5,923.94
PE Ratio	8.79
Forward PE	7.85
Dividend	3,000.00 (5.76%)
Ex-Dividend Date	Mar 21, 2025

Volume	122,516
Average Volume	20,106
Open	51,300
Previous Close	51,700
Day's Range	51,300 - 56,600
52-Week Range	47,700 - 64,900
Beta	0.33
RSI	45.17
Earnings Date	Oct 23, 2025

About HNX:DP3

Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturin...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DP3

Financial Performance

In 2024, HNX:DP3's revenue was 417.49 billion, an increase of 1.89% compared to the previous year's 409.73 billion. Earnings were 121.17 billion, a decrease of -3.27%.